Collaborations

Professor Routier’s group is involved in scientific collaborations with both academic and industrial partners. By bringing together chemists, computer scientists, biologists, clinical practitioners, and industrial partners the group is part of a functional network to bring active molecules through to drug candidates for the treatment or the diagnosis of diseases.

Collaboration with regional and national research valorization services :

  • C-VALO/FEDER*, Maturation project PELICAN: Preclinical validation of LIMK inhibitors, kinases involved in cytoskeleton dynamics in glioblastomas. Principal investigators : Dr. H. Bénédetti (CBM) and Pr. S. Routier (ICOA).
  • CNRS Innovation, Pre-maturation project : Preclinical validation of LIMK inhibitors in cancer. Principal investigators : Dr. H. Bénédetti (CBM) and Pr. S. Routier (ICOA) in collaboration with Dr. F. Verrechia, Nantes University.

 *This project was financed by the European Union. Europe is committed in the Centre-Val de Loire region with the European Regional Development Fund.

Chemistry:

  • M. Aksirra, S. Lazar, Hassan II, Mohammédia, Morocco.
  • J.P. Bazureau, B. Carbonni, F. Carreau, Université de Rennes.
  • S. Brindell, M. Lewinski, Université de Cracovie, Poland.
  • A. Finaru, Université de Bacau, Romania.
  • G. Guillaumet, F. Suzenet, A. Tatibouët, ICOA, Orléans.
  • G. Hartmann, S. Obermarchais, Sarrebruck, Germany.
  • L. Jean, P.Y. Renard, COBRA, Rouen.
  • C. Logé, P. Marchand, J.M. Robert, Nantes.
  • L. Profire, Faculté pharmacie et médecine de Iasi, Romania.
  • S. Rosca, R. Stan, Polytechnique de Bucarest, Romania.
  • V. Thiery, La Rochelle.
  • Y. Troin, ENSCCF- Clermont Ferrand.

 

Crystallography:

  • A.N. Bullock, S. Knapp, Cambridge University, England.
  • J. Guillon, M. Marchivie, S. Massip, Bordeaux.

 

Biology – Molecular biology:

  • H. Benedetti, M. Cadène, E. Jakab Toth , S. Petoud, CBM, CNRS, Orléans.
  • F. Bodéré-Kraeber, S. Marionneau-Lambot, J-F. Cartron, Inserm CHU Nantes, Nantes.
  • S. Chalon, INSERM, CHU Tours.
  • M-H. Cordonnier, IRCL Lille.
  • A. Corlu, R. Le Guével, Plateforme ImPACcell, Rennes.
  • I. Da Silva, T. Sauvage, CEMHTI, Orléans.
  • R. Kiss, Université Libre de Bruxelles, Belgium.
  • A. Le Pape CIPA Orléans.
  • F. Leroux, C. Piveteau, Université de Lille 2.
  • M. Potier-Cartereau, C. Vandier, INSERM, Tours.
  • S. Ruchaud, CNRS, Station Biologique, Roscoff

 

Radiochimistry:

  • J. Vercouillie, INSERM, Tours.

 

Cliniciens:

  • J.Y. Douillard, INSERM, CHU Nantes.
  • D. Guilloteau, INSERM, Tours.
  • M.L. Jourdan, CHU Tours.
  • A. Lansiaux, INSERM, IRC et Centre Oscar Lambret, Lille

 

Molecular modelization:

  • S. Aci-Séche, P. Bonnet, S. Bourg, ICOA, Orléans.

 

Analytical chemistry:

  • A. Chartier, R; Nehmé, P. Morin, C. West, ICOA, Orléans.

 

Chemical engineering:

  • S. Bostyn, ICARE, CNRS Orléans.

 

Industrial Parners:

  • C. Bailly, J. Fahy, F. Schmitt, F. Marion, F. Lieby-Muller, Institut de Recherches Pierre Fabre, Toulouse.
  • K. Bertrand, R. Walzack, M. Dubernet, GENFIT, Loos.
  • J-C. Bizot, F. Trovero, KEY-OBS, Orléans.
  • P-L. Brun, E. Peslherbe, Y. Robin, ISOCHEM, Pithiviers.
  • L. Botez, G. De Nanteuil, P. Gloanec, AM Chollet Institut de Recherches Servier, Les Laboratoires Servier, Neuilly sur Seine.
  • L. Meijer, H. Galons, MANROS Therapeutics, Roscoff
  • J. Mercier, C. Pégurier UCB Pharma SA, Belgium
  • S. Richard, P. Champeroux CERB
  • C. Chesnes, C. Guillouzo, BIOPREDIC, Rennes
  • F. Bree, Xenoblis, Rennes

 

“Cancéropôle Grand Ouest” Collaborations: